Activation of PPARγ reverses a defect of surfactant synthesis in mice lacking two types of fatty acid binding protein

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 6-7, 2008, Pages 314-320

  Schachtrup, Christian ^a   Malcharek, Stefan ^a   Haitsma, Jack J ^b   Lachmann, Burkhard ^b   Owada, Yuji ^c   Binas, Bert ^d   Kondo, Hisatake ^c   Rüstow, Bernd ^e   Galla, Hans Joachim ^a   Spener, Friedrich ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TEXAS A AND M UNIVERSITY   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Fatty acid binding protein; Fatty acid signaling; Lung compliance; Phospholipid synthesis; Surfactant organisation

Indexed keywords

FATTY ACID BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; SURFACTANT; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; LUNG SURFACTANT; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILAYER MEMBRANE; KNOCKOUT MOUSE; LIPID METABOLISM; LUNG COMPLIANCE; LUNG FUNCTION; MOUSE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE;

MUS;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; HYPOGLYCEMIC AGENTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PPAR GAMMA; PULMONARY SURFACTANTS; THIAZOLIDINEDIONES;

EID: 48749109440     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.04.010     Document Type: Article

References (44)

1. Hihi A.K., Michalik L., and Wahli W. PPARs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 59 (2002) 790-798
2. Michalik L., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member. Curr. Opin. Lipidol. 14 (2003) 129-135
3. Lee C.H., Olson P., and Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 (2003) 2201-2207
4. Haunerland N.H., and Spener F. Fatty acid-binding proteins - insights from genetic manipulations. Prog. Lipid Res. 43 (2004) 328-349
5. Glatz J.F., and van der Vusse G.J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 35 (1996) 243-282
6. Storch J., and Thumser A.E. The fatty acid transport function of fatty acid-binding proteins. Biochim. Biophys. Acta 1486 (2000) 28-44
7. Wolfrum C., Borrmann C.M., Börchers T., and Spener F. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2323-2328
8. Tan N.S., Shaw N.S., Vinckenbosch N., Liu P., Yasmin R., Desvergne B., Wahli W., and Noy N. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol. 22 (2002) 5114-5127
9. Adida A., and Spener F. Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell. Biochim. Biophys. Acta 1761 (2006) 172-181
10. Guthmann F., Schachtrup C., Tolle A., Wissel H., Binas B., Kondo H., Owada Y., Spener F., and Rüstow B. Phenotype of palmitic acid transport and of signalling in alveolar type II cells from E/H-FABP double-knockout mice: contribution of caveolin-1 and PPARγ. Biochim. Biophys. Acta 1636 (2004) 196-204
11. Van Golde L.M., Batenburg J.J., and Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol. Rev. 68 (1988) 374-455
12. Bourdos N., Kollmer F., Benninghoven A., Ross M., Sieber M., and Galla H.J. Analysis of lung surfactant model systems with time-of-flight secondary ion mass spectrometry. Biophys. J. 79 (2000) 357-369
13. Piknova B., Schram V., and Hall S.B. Pulmonary surfactant: phase behavior and function. Curr. Opin. Struct. Biol. 12 (2002) 487-494
14. Ding J., Takamoto D.Y., von Nahmen A., Lipp M.M., Lee K.Y., Waring A.J., and Zasadzinski J.A. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. Biophys. J. 80 (2001) 2262-2272
15. Schief W.R., Antia M., Discher B.M., Hall S.B., and Vogel V. Liquid-crystalline collapse of pulmonary surfactant monolayers. Biophys. J. 84 (2003) 3792-3806
16. Haagsman H.P., Hawgood S., Sargeant T., Buckley D., White R.T., Drickamer K., and Benson B.J. The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J. Biol. Chem. 262 (1987) 13877-13880
17. Rouser G., Siakotos A.N., and Fleisher S. Quantitative analysis of phospholipid by thin-layer chromatography and phosphorus analysis of spots. Lipids 1 (1966)
18. Udenfriend S., Stein S., Bohlen P., Dairman W., Leimgruber W., and Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178 (1972) 871-872
19. von Nahmen A., Post A., Galla H.J., and Sieber M. The phase behavior of lipid monolayers containing pulmonary surfactant protein C studied by fluorescence light microscopy. Eur. Biophys. J. 26 (1997) 359-369
20. Ross M., Krol S., Janshoff A., and Galla H.J. Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C. Eur. Biophys. J. 31 (2002) 52-61
21. Dobbs L.G., Gonzalez R., and Williams M.C. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134 (1986) 141-145
22. Kolleck I., Wissel H., Guthmann F., Schlame M., Sinha P., and Rüstow B. HDL-holoparticle uptake by alveolar type II cells: effect of vitamin E status. Am. J. Respir. Cell. Mol. Biol. 27 (2002) 57-63
23. Piumngam P., Schachtrup C., Owada Y., Kondo H., Promptmas C., and Spener F. Expression of liver-type fatty acid-binding protein in murine lung and its release into serum upon challenge of lung with lipopolysaccharide. Eur. J. Lipid Sci. Technol. 107 (2005) 145-152
24. Guthmann F., Hohoff C., Fechner H., Humbert P., Börchers T., Spener F., and Rüstow B. Expression of fatty-acid-binding proteins in cells involved in lung-specific lipid metabolism. Eur. J. Biochem. 253 (1998) 430-436
25. Miotla J.M., Teixeira M.M., and Hellewell P.G. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am. J. Respir. Cell. Mol. Biol. 18 (1998) 411-420
26. Schachtrup C., Scholzen T.E., Grau V., Luger T.A., Sorg C., Spener F., and Kerkhoff C. L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: evidence for a PPARalpha-independent expression. Int. J. Biochem. Cell Biol. 36 (2004) 2042-2053
27. Tontonoz P., Hu E., Graves R.A., Budavari A.I., and Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234
28. Simon T.C., Roth K.A., and Gordon J.I. Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J. Biol. Chem. 268 (1993) 18345-18358
29. Hanhoff T., Lücke C., and Spener F. Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell Biochem. 239 (2002) 45-54
30. Kingma P.B., Bok D., and Ong D.E. Bovine epidermal fatty acid-binding protein: determination of ligand specificity and cellular localization in retina and testis. Biochemistry 37 (1998) 3250-3257
31. Richieri G.V., Ogata R.T., and Kleinfeld A.M. Thermodynamic and kinetic properties of fatty acid interactions with rat liver fatty acid-binding protein. J. Biol. Chem. 271 (1996) 31068-31074
32. Weibel E.R., Kistler G.S., and Tondury G. A stereologic electron microscope study of "tubular myelin figures" in alveolar fluids of rat lungs. Z. Zellforsch. Mikrosk. Anat. 69 (1966) 418-427
33. Schurch S., Green F.H., and Bachofen H. Formation and structure of surface films: captive bubble surfactometry. Biochim. Biophys. Acta 1408 (1998) 180-202
34. von Nahmen A., Schenk M., Sieber M., and Amrein M. The structure of a model pulmonary surfactant as revealed by scanning force microscopy. Biophys. J. 72 (1997) 463-469
35. Amrein M., von Nahmen A., and Sieber M. A scanning force- and fluorescence light microscopy study of the structure and function of a model pulmonary surfactant. Eur. Biophys. J. 26 (1997) 349-357
36. Knebel D., Sieber M., Reichelt R., Galla H.J., and Amrein M. Scanning force microscopy at the air-water interface of an air bubble coated with pulmonary surfactant. Biophys. J. 82 (2002) 474-480
37. Kramer A., Wintergalen A., Sieber M., Galla H.J., Amrein M., and Guckenberger R. Distribution of the surfactant-associated protein C within a lung surfactant model film investigated by near-field optical microscopy. Biophys. J. 78 (2000) 458-465
38. Harbottel R.R., Nag K., McIntyre N.S., Possmayer F., and Petersen N.O. Molecular organization revealed by time-of-flight secondary ion mass spectrometry of a clinically used extracted pulmonary surfactant. Langmuir 19 (2003) 3698-3704
39. Gopal A., and Lee E.J. Morphology and collapse transitions in binary phospholipid monolayers. J. Phys. Chem. B 105 (2001) 10348-10354
40. Nogee L.M. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu. Rev. Physiol. 66 (2004) 601-623
41. Malcharek S., Bourdos N., and Galla H.J. Analysis of surface topology and chemical composition of microstructures formed in planar surfactant films under compression. In: Nag K. (Ed). Lung Surfactant Function and Disorder (2005), Taylor & Francis Group, Boca Raton FL 251-274
42. Sano H., and Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 42 (2005) 279-287
43. Malcharek S., Hinz A., Hilterhaus L., and Galla H.J. Multilayer structures in lipid monolayer films containing surfactant protein C: effects of cholesterol and POPE. Biophys. J. 88 (2005) 2638-2649
44. Panda A.K., Nag K., Harbottle R.R., Rodriguez-Capote K., Veldhuizen R.A., Petersen N.O., and Possmayer F. Effect of acute lung injury on structure and function of pulmonary surfactant films. Am. J. Respir. Cell. Mol. Biol. 30 (2004) 641-650